Opioid agonist and antagonist treatment differentially regulates immunoreactive μ-opioid receptors and dynamin-2 in vivo

European Journal of Pharmacology

Volumn 498, Issue 1-3, 2004, Pages 87-96

  Yoburn, Byron C ^a   Purohit, Vishal ^a   Patel, Kaushal ^a   Zhang, Qiuyu ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

Opioid receptor; Down regulation; Intermittent and continuous dosing; Up regulation

Indexed keywords

DYNAMIN II; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ETORPHINE; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; NALTREXONE; OPIATE AGONIST; OPIATE ANTAGONIST; RADIOLIGAND;

ARTICLE; BINDING ASSAY; CONTROLLED STUDY; DENSITY; DOWN REGULATION; DRUG DELIVERY SYSTEM; EVALUATION; IMMUNOBLOTTING; IMMUNOREACTIVITY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; SPINAL CORD; SYNTHESIS; UPREGULATION; WESTERN BLOTTING;

ANALGESICS, OPIOID; ANIMALS; BINDING, COMPETITIVE; BLOTTING, WESTERN; DYNAMIN II; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ETORPHINE; MALE; MICE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; RADIOLIGAND ASSAY; RECEPTORS, OPIOID, MU; SPINAL CORD;

EID: 4444234066     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.07.052     Document Type: Article

References (44)

1. V.A. Alvarez, S. Arttamangkul, V. Dang, A. Salem, J.L. Whistler, M. Von Zastrow, D.K. Grandy, and J.T. Williams mu-Opioid receptors: Ligand-dependent activation of potassium conductance, desensitization, and internalization J. Neurosci. 22 2002 5769 5776
2. A.C. Barrett, E.S. Smith, and M.J. Picker Use of irreversible antagonists to determine the relative efficacy of mu-opioids in a pigeon drug discrimination procedure: comparison of beta-funaltrexamine and clocinnamox J. Pharmacol. Exp. Ther. 305 2003 1061 1070
3. S.L. Borgland, M. Connor, P.B. Osborne, J.B. Furness, and M.J. Christie Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opioid receptors J. Biol. Chem. 278 2003 18776 18784
4. H.R. Bourne, and M. Von Zastrow Drug Receptor and Pharmacodynamics B.G. Katzung Basic and Clinical Pharmacology 9th ed. 2004 Lange Medical Books/McGraw Hill New York 11 13
5. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
6. L.S. Brady, M. Herkenham, R.B. Rothman, J.S. Partilla, M. Konig, A.M. Zimmer, and A. Zimmer Region-specific up-regulation of opioid receptor binding in enkephalin knockout mice Brain. Res. Mol. Brain Res. 68 1999 193 197
7. J. Celver, M. Xu, W. Jin, J. Lowe, and C. Chavkin Distinct domains of the mu-opioid receptor control uncoupling and internalization Mol. Pharmacol. 65 2004 528 537
8. S. Chakrabarti, W. Yang, P.Y. Law, and H.H. Loh The mu-opioid receptor down-regulates differently from the delta-opioid receptor: requirement of a high affinity receptor/G protein complex formation Mol. Pharmacol. 52 1997 105 113
9. S.C. Chang, K. Lutfy, V. Sierra, and B.C. Yoburn Dissociation of opioid receptor upregulation and functional supersensitivity Pharmacol. Biochem. Behav. 38 1991 853 859
10. D.L. Cichewicz, V.L. Haller, and S.P. Welch Changes in opioid and cannabinoid receptor protein following short-term combination treatment with delta(9)-tetrahydrocannabinol and morphine J. Pharmacol. Exp. Ther. 297 2001 121 127
11. B.M. Cox, and A.T. Crowder Receptor domains regulating mu-opioid receptor uncoupling and internalization: relevance to opioid tolerance Mol. Pharmacol. 65 2004 492 495
12. A. Duttaroy, and B.C. Yoburn The effect of intrinsic efficacy on opioid tolerance Anesthesiology 82 1995 1226 1235
13. A. Duttaroy, and B.C. Yoburn In vivo regulation of mu-opioid receptor density and gene expression in CXBK and outbred Swiss Webster mice Synapse 37 2000 118 124
14. A. Duttaroy, J. Shen, S. Shah, B. Chen, F. Sehba, J. Carroll, and B.C. Yoburn Opioid receptor upregulation in mu-opioid receptor deficient CXBK and outbred Swiss Webster mice Life Sci. 65 1999 113 123
15. P.J. Emmerson, M.J. Clark, A. Mansour, H. Akil, J.H. Woods, and F. Medzihradsky Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu-opioid receptor J. Pharmacol. Exp. Ther. 278 1996 1121 1127
16. S.S. Ferguson Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling Pharmacol. Rev. 53 2001 1 24
17. B.A. Gomes, J. Shen, K. Stafford, M. Patel, and B.C. Yoburn Mu-opioid receptor down-regulation and tolerance are not equally dependent upon G-protein signaling Pharmacol. Biochem. Behav. 72 2002 273 278
18. D.E. Keith, S.R. Murray, P.A. Zaki, P.C. Chu, D.V. Lissin, L. Kang, C.J. Evans, and M. von Zastrow Morphine activates opioid receptors without causing their rapid internalization J. Biol. Chem. 271 1996 19021 19024
19. D.E. Keith, B. Anton, S.R. Murray, P.A. Zaki, P.C. Chu, D.V. Lissin, G. Monteillet-Agius, P.L. Stewart, C.J. Evans, and M. von Zastrow mu-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain Mol. Pharmacol. 53 1998 377 384
20. T. Kenakin Pharmacological Analysis of Drugâ€"Receptor Interaction 3rd ed. 1997 Raven Press New York, NY
21. J. Li, C. Chen, P. Huang, and L.Y. Liu-Chen Inverse agonist up-regulates the constitutively active D3.49(164)Q mutant of the rat mu-opioid receptor by stabilizing the structure and blocking constitutive internalization and down-regulation Mol. Pharmacol. 60 2001 1064 1075
22. J.G. Li, J.L. Benovic, and L.Y. Liu-Chen Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulation Mol. Pharmacol. 58 2000 795 801
23. C.N. Patel, V. Rajashekara, K. Patel, V. Purohit, and B.C. Yoburn Chronic opioid antagonist treatment selectively regulates trafficking and signaling proteins in mouse spinal cord Synapse 50 2003 67 76
24. M. Patel, B. Gomes, C. Patel, and B.C Yoburn Antagonist-induced μ-opioid receptor up-regulation decreases G-protein receptor kinase-2 and dynamin-2 abundance in mouse spinal cord Eur. J. Pharmacol. 446 2002 37 42
25. M.B. Patel, C.N. Patel, V. Rajashekara, and B.C. Yoburn Opioid agonists differentially regulate mu-opioid receptors and trafficking proteins in vivo Mol. Pharmacol. 62 2002 1464 1470
26. U.E. Petaja-Repo, M. Hogue, S. Bhalla, A. Laperriere, J.P. Morello, and M. Bouvier Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation EMBO J. 21 2002 1628 1637
27. K.L. Pierce, R.T. Premont, and R.J. Lefkowitz Seven-transmembrane receptors Nat. Rev., Mol. Cell Biol. 9 2002 639 650
28. V. Rajashekara, C.N. Patel, K. Patel, V. Purohit, and B.C. Yoburn Chronic opioid antagonist treatment dose-dependently regulates mu-opioid receptors and trafficking proteins in vivo Pharmacol. Biochem. Behav. 75 2003 909 913
29. F. Sehba, A. Duttaroy, S. Shah, B. Chen, J. Carroll, and B.C. Yoburn In vivo homologous regulation of mu-opioid receptor gene expression in the mouse Eur. J. Pharmacol. 339 1997 33 41
30. S. Shah, A. Duttaroy, B.T. Chen, J. Carroll, and B.C. Yoburn The effect of mu-opioid receptor antisense on morphine potency and antagonist-induced supersensitivity and receptor upregulation Brain Res. Bull. 42 1997 479 484
31. J. Shen, Gomes A. Benedict, A. Gallagher, K. Stafford, and B.C. Yoburn Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice Synapse 38 2000 322 327
32. K. Stafford, A.B. Gomes, J. Shen, and B.C. Yoburn mu-Opioid receptor downregulation contributes to opioid tolerance in vivo Pharmacol. Biochem. Behav. 69 2001 233 237
33. R.P. Stephenson A modification of receptor theory Br. J. Pharmacol. 11 1956 379 393
34. A. Tempel, S.M. Crain, E.R. Peterson, E.J. Simon, and R.S. Zukin Antagonist-induced opiate receptor upregulation in cultures of fetal mouse spinal cord-ganglion explants Brain Res. 390 1986 287 291
35. E.M. Unterwald, B. Anton, T. To, H. Lam, and C.J. Evans Quantitative immunolocalization of mu-opioid receptors: regulation by naltrexone Neuroscience 85 1998 897 905
36. E.M. Unterwald, J.M. Rubenfeld, Y. Imai, J.B. Wang, G.R. Uhl, and M.J. Kreek Chronic opioid antagonist administration upregulates mu-opioid receptor binding without altering mu-opioid receptor mRNA levels Brain Res. Mol. Brain Res. 33 1995 351 355
37. E.A. Walker, G. Zernig, and A.M. Young In vivo apparent affinity and efficacy estimates for mu opiates in a rat tail-withdrawal assay Psychopharmacology (Berl.) 136 1998 15 23
38. J.L. Whistler, H.H. Chuang, P. Chu, L.Y. Jan, and M. von Zastrow Functional dissociation of mu-opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction Neuron 23 1999 737 746
39. B.C. Yoburn, B. Billings, and A. Duttaroy Opioid receptor regulation in mice J. Pharmacol. Exp. Ther. 265 1993 314 320
40. B.C. Yoburn, B.A. Gomes, V. Rajashekara, C. Patel, and M. Patel Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo Synapse 47 2003 109 116
41. Y. Yu, L. Zhang, X. Yin, H. Sun, G.R. Uhl, and J.B. Wang Mu-opioid receptor phosphorylation, desensitization, and ligand efficacy J. Biol. Chem. 272 1997 28869 28874
42. J.E. Zadina, L.M. Harrison, L.J. Ge, A.J. Kastin, and S.L. Chang Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells J. Pharmacol. Exp. Ther. 270 1994 1086 1096
43. P.A. Zaki, D.E. Keith Jr, G.A. Brine, F.I. Carroll, and C.J. Evans Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation? J. Pharmacol. Exp. Ther. 292 2000 1127 1134
44. R.S. Zukin, and A. Tempel Neurochemical correlates of opiate receptor regulation Biochem. Pharmacol. 35 1986 1623 1627